Most patients begin to notice changes in body composition, energy, or recovery within 46 weeks, though optimal results are typically seen after 812 weeks of consistent use, alongside healthy lifestyle habits
Typical protocol: 300mcg AOD-9604 fasted AM + 12mg Tesamorelin pre-bed AOD-9604 + GLP-1 (Semaglutide / Retatrutide) The mechanism split here is elegant: GLP-1 agonists handle appetite suppression, slowed gastric emptying, and overall caloric intake reduction
As an NNMT inhibitor, it is associated with reduced white adipose tissue, improved NAD+ availability, and support for insulin sensitivity
The Body Shop IV Infusion Therapy
Each combination serves different goals
No, clinical trials definitively demonstrated that AOD-9604 has no effect on serum IGF-1 levels